14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Nov 19, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 18, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 15, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 14, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 13, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 12, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 11, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 08, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 07, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 06, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 05, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 04, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Nov 01, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 31, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 30, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 29, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 28, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 25, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 24, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 23, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 22, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 21, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 18, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 17, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Oct 16, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT